Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis

细胞间相互作用定义了维持胎膜稳态的细胞迁移和转变

基本信息

  • 批准号:
    10571858
  • 负责人:
  • 金额:
    $ 43.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-12 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Fetal membranes (amniochorion) protect the fetus during pregnancy. At term, senescence (aging) and inflammation cause functional and mechanical instability to membrane cells, contributing to parturition. Premature senescence and membrane dysfunctions are associated with preterm birth (PTB) and preterm premature rupture of the membranes (pPROM). However, cellular-level changes contributing to membrane stability during gestation and its dysfunction leading to labor and delivery are still unclear. Recent studies of senescent term and preterm membranes revealed “microfractures” (MFs), sites of cellular remodeling. MFs are resealed during gestation to maintain membrane integrity. Higher numbers of MFs and their increased morphometry (depth and width) in term labor, pPROM, and PTB membranes compared to respective controls suggest MFs' resealing is compromised. Amnion epithelial cells in MFs have been observed undergoing epithelial mesenchymal transition (EMT). Further, these cells showed proliferative and resealing properties of deepithelialized (nude/cell free) areas to stabilize membranes. At the healing edge of MFs, amnion mesenchymal cells exhibited a reverse phenomenon, mesenchymal-epithelial transition (MET). From these findings, we postulate that cellular transitions are essential for maintaining fetal membrane integrity. We hypothesize that MFs are areas of membrane remodeling and their increased number and morphometry are associated with failure to remodel and dysfunctional membranes. Understanding intercellular and cell-matrix interactions causing MFs' development and their resealing will help us to determine how oxidative stress (OS) and inflammation can contribute to the persistence of MFs and dysfunctional membrane status in PTB and pPROM. Two specific aims to be tested are Specific Aim 1: To investigate the dynamic remodeling of the fetal membrane epithelium in an in vitro model of cell-free (nude) membranes during OS and infection / inflammation compared to normal conditions; Specific Aim 2: To determine cell migration, matrix degradation, and cellular transition associated with MFs' formation using a fetal membrane organ-on-a-chip approach. This multidisciplinary proposal combines cell and molecular biological and bioengineering approaches designed to overcome the limitations of classic 2D cell cultures by developing a fetal membrane-on-a-chip using organ-on-chip technologies. This model system will maintain multiple cell types in close proximity with constant dynamic interactions, similar to the conditions in utero. We will elucidate causative molecular mechanisms of (normal and abnormal) biologic MFs' formation and how they contribute to PTB and pPROM. Understanding cellular-level mechanisms will allow us to design strategies to minimize MFs' development to strengthen intrauterine cavities and reduce the risk of PTB and pPROM.
胎膜(羊膜)在怀孕期间保护胎儿。在足月,衰老(老化)和炎症导致膜细胞功能和机械不稳定,有助于分娩。过早衰老和膜功能障碍与早产(PTB)和胎膜早破(pPROM)有关。然而,细胞水平的变化对妊娠期膜稳定性的影响及其导致分娩和分娩的功能障碍仍不清楚。最近对衰老足月和早产儿膜的研究发现了“微骨折”(MFs),这是细胞重塑的部位。MFs在妊娠期间被重新密封以保持膜的完整性。与对照组相比,足月产程、pPROM和PTB膜中MFs的数量和形态(深度和宽度)的增加表明MFs的再密封受到损害。羊膜上皮细胞发生上皮间充质转化(epithelial mesenchymal transition, EMT)。此外,这些细胞在深度上皮化(裸细胞/无细胞)区域表现出增殖和再密封特性,以稳定膜。在MFs愈合边缘,羊膜间充质细胞表现出相反的现象,即间充质-上皮转化(MET)。根据这些发现,我们假设细胞转化对于维持胎膜完整性是必不可少的。我们

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arum Han其他文献

Arum Han的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arum Han', 18)}}的其他基金

3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth
3D 生物制造胎儿-母体界面组织模型,用于确定妊娠期间的药物疗效,以降低早产风险
  • 批准号:
    10438407
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
Project 3
项目3
  • 批准号:
    10349753
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth
3D 生物制造胎儿-母体界面组织模型,用于确定妊娠期间的药物疗效,以降低早产风险
  • 批准号:
    10670735
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
Project 3
项目3
  • 批准号:
    10707445
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
Administrative Supplement to Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis
细胞间相互作用的行政补充定义了维持胎膜稳态的细胞迁移和转变
  • 批准号:
    10177264
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip
通过使用芯片上的母胎界面开发基于细胞外囊泡的早产疗法
  • 批准号:
    10434794
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis
细胞间相互作用定义了维持胎膜稳态的细胞迁移和转变
  • 批准号:
    10356919
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Accelerating discovery of neutralizing paratopes with Functional Antibody Screening Technology
利用功能性抗体筛选技术加速中和互补位的发现
  • 批准号:
    10088379
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip
通过使用芯片上的母胎界面开发基于细胞外囊泡的早产疗法
  • 批准号:
    10037855
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip
通过使用芯片上的母胎界面开发基于细胞外囊泡的早产疗法
  • 批准号:
    10492233
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:

相似海外基金

Targeting fetal lung macrophage dysregulation in congenital diaphragmatic hernia with amniotic fluid stem cell extracellular vesicle therapy
羊水干细胞胞外囊泡治疗针对先天性膈疝胎儿肺巨噬细胞失调
  • 批准号:
    479991
  • 财政年份:
    2023
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Operating Grants
Mechanisms of epidermal differentiation by hypoxia response and identification of amniotic fluid-derived factors
缺氧反应引起的表皮分化机制及羊水源性因子的鉴定
  • 批准号:
    23H02136
  • 财政年份:
    2023
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Early Treatment With H12-(ADP)-liposomes Ameliorates Post-partum Hemorrhage With Coagulopathy Caused by Amniotic Fluid Embolism in Rabbits.
H12-(ADP)-脂质体的早期治疗可改善兔羊水栓塞引起的产后出血和凝血病。
  • 批准号:
    23K08828
  • 财政年份:
    2023
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a novel amniotic fluid biomarker to predict the prognosis of fetal growth restriction
建立一种新型羊水生物标志物来预测胎儿生长受限的预后
  • 批准号:
    23K15809
  • 财政年份:
    2023
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of fetal stem cell therapy for cleft lip using sandwich-graft composed of bandage epithelial tissue(BET) and amniotic fluid spheroid
使用绷带上皮组织(BET)和羊水球体组成的三明治移植物开发胎儿干细胞治疗唇裂
  • 批准号:
    21K21032
  • 财政年份:
    2021
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Automatic Segmentation of Amniotic Fluid using Deep Learning
使用深度学习自动分割羊水
  • 批准号:
    565347-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Investigation of the coagulopathy involving amniotic fluid embolism: Towards development of the specific earlier assessment
涉及羊水栓塞的凝血障碍的调查:制定具体的早期评估
  • 批准号:
    21K16811
  • 财政年份:
    2021
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Verification of therapeutic effects by amniotic fluid stem cell sheet for rat myelomeningocele model.
羊水干细胞片对大鼠脊髓脊膜膨出模型治疗效果的验证。
  • 批准号:
    21K16599
  • 财政年份:
    2021
  • 资助金额:
    $ 43.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Extracellular vesicles derived from amniotic fluid stem cells normalize glomerular function during progressive kidney disease.
来自羊水干细胞的细胞外囊泡在进行性肾脏疾病期间使肾小球功能正常化。
  • 批准号:
    10348192
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Extracellular vesicles derived from amniotic fluid stem cells normalize glomerular function during progressive kidney disease.
来自羊水干细胞的细胞外囊泡在进行性肾脏疾病期间使肾小球功能正常化。
  • 批准号:
    10549376
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了